Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ
J Neuropathol Exp Neurol. 1998 57 (5): 415-25

PMID: 9596412 · DOI:10.1097/00005072-199805000-00005

MeSH Terms (17)

Aged Aged, 80 and over Aldehydes Alzheimer Disease Antibody Specificity Apolipoproteins E Blotting, Western Brain Chemistry Cell Line Cysteine Proteinase Inhibitors Dementia Genotype Humans Immunohistochemistry Immunotoxins Lewy Bodies Oxidation-Reduction

Connections (1)

This publication is referenced by other Labnodes entities: